Overview

Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of intravenous Exenatide therapy in hyperglycemic patients admitted to the coronary intensive care unit.
Phase:
Phase 4
Details
Lead Sponsor:
Saint Luke's Health System
Collaborator:
Amylin Pharmaceuticals, LLC.
Treatments:
Exenatide